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phropathy. l-Arginine treatment inhibits collagen type IV syn-L-Arginine treatment may prevent tubulointerstitial nephropa-
thesis possibly by suppressing macrophage invasion and thethy caused by germanium dioxide.
resultant TGF-b1 expression in this nephropathy. l-ArginineBackground. Long-term oral ingestion of germanium diox-
treatment may be beneficial in the prevention of tubulointersti-ide (GeO2) causes progressive renal failure derived from tubu-
tial fibrosis, which is considered to be the terminal stage oflointerstitial nephropathy in humans and animals. The charac-
GeO2-induced nephropathy.teristic of GeO2-induced nephropathy is the renal tissue injury
persisting for a long time, even after cessation of GeO2 inges-
tion. However, a treatment that can suppress the long-lasting
renal tissue injury has not yet been established.
Germanium (Ge), carbon (C), tin (Sn), and lead (Pb),Methods. Using the methods of immunohistochemistry and
all belong to group IV of the periodic system. Ge hasreverse transcription-polymerase chain reaction, we examined
the expression of ED1-positive cells (macrophages/monocytes), been utilized in the industrial field as a semiconductor
transforming growth factor (TGF)-b1 mRNA and protein and and in the production of lenses [1]. Ge compounds, par-
collagen type IV mRNA and protein in the kidneys of rats ticularly organogermanium derivatives, are known to havewith GeO2-induced nephropathy. Concomitantly, the effects
some biological activities including anti-tumor effectsof l-arginine treatment on their expression was explored in
and immunomodulative actions [2, 3]. These compoundsthe kidneys of rats with GeO2-induced nephropathy.
Results. Chronic administration of GeO2 caused tubulointer- were previously used to maintain good health and as a
stitial nephropathy characterized by leukocyte invasion into panacea for patients with cancer or AIDS in Japan, the
the enlarged tubulointerstitial space in rats. The expression of USA and some European countries [4]. Consequently,ED1-positive cells, TGF-b1 protein and collagen type IV pro-
it was noted that long-term oral ingestion of Ge com-tein was markedly increased in the tubulointerstitium of the
pounds led to progressive renal failure in humans. Therenal cortex from rats with GeO2-induced nephropathy. Simi-
larly, TGF-b1 and collagen type IV mRNA were significantly causative substances are now considered to be either
enhanced in the renal cortex of rats with GeO2-induced ne- germanium dioxide (GeO2) [5–7] or germanium lactatephropathy. A small number of tubulointerstitial cells express-
citrate [4, 8, 9].ing TGF-b1 protein were also observed in the renal cortex
The histopathological findings concerning GeO2-inducedof rats with GeO2-induced nephropathy. However, l-arginine
treatment led to a parallel decrease in the expression of ED1- nephropathy are characterized by tubulointerstitial ne-
positive cells, TGF-b1 mRNA and collagen type IV mRNA phropathy with no remarkable changes in glomeruli
and protein in rats with GeO2-induced nephropathy. [7, 10]. The sites of the tubular injury caused by GeO2Conclusions. In general, collagen synthesis is driven by
are the distal tubules and the collecting ducts [10]. ATGF-b1 in the fibrotic process associated with a variety of renal
clinical feature of this nephropathy is subacute renaldisorders. TGF-b1 is secreted by TGF-b1 producing cells such as
macrophages, fibroblasts and myofibroblasts. Thus, the present failure, although there have been no abnormal findings
study indicates that the expression of collagen type IV may be such as proteinuria or hematuria in the urine [7, 10].
mediated by TGF-b1 released from invading macrophages and, However, the most important characteristic is the long-to a lesser extent, released from tubulointerstitial cells, presum-
lasting renal dysfunction, based on the renal tissue dam-ably fibroblasts and/or myofibroblasts in GeO2-induced ne-
age, that persists even after cessation of germanium-
containing compounds [7, 8, 10]. Studies by Sanai et
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al have demonstrated that long-term administration ofbroblasts, myofibroblasts, nephrotoxicity, industrial toxins, tubular in-
jury. GeO2 causes tubulointerstitial nephropathy in rats as
well as in humans [10]. The same has been described inReceived for publication June 28, 1999
European patients after long-term ingestion of germa-and in revised form November 10, 1999
Accepted for publication January 10, 2000 nium lactate citrate [4, 8].
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ticularly TGF-b1, plays a central role in the regulation tion of GeO2. The amount of GeO2 ingested by the rats
in the GeO2 diet group (N 5 18) amounted to 5.16 6of the collagen accumulation that contributes to the for-
mation of tubulointerstitial fibrosis [11, 12]. In the kid- 0.48 (means 6 SD) g over the 20 weeks. The induction
of tubulointerstitial nephropathy was examined in a histo-neys, TGF-b1 is mainly expressed in tubules, glomeruli,
invading macrophages and interstitial cells [11, 13, 14]. It pathological study using kidney sections, which were
stained with hematoxylin and eosin (H&E), from anotherwas recently reported that l-arginine treatment blocked
macrophage infiltration and the resultant interstitial cell group of rats at 16 weeks after the start of the GeO2 diet
(standard diet, N 5 6 and GeO2 diet, N 5 10). All ratsinvolvement and collagen type IV synthesis in tubuloin-
terstitial fibrosis associated with ureteral obstruction and (N 5 39) involved in the final study were allowed free
access to tap water until the start of the l-arginine treat-puromycin-induced nephrosis [15, 16]. These findings
suggest the importance of early macrophage infiltration ment.
Following the histopathological study, rats from bothin the TGF-b1-induced collagen deposition seen in tubu-
lointerstitial fibrosis. the standard diet group and the GeO2 diet group were
further divided into two groups each and given tap waterAs shown by Sanai et al [10] and also demonstrated
in the present study, the long-term oral ingestion of GeO2 alone (standard diet, N 5 9 and GeO2 diet, N 5 18) or
1% l-arginine dissolved in tap water (N 5 6 in eachleads to tubulointerstitial nephropathy in rats, and it is
of enormous value to find a means to block the activity group) [14, 15] for the last three weeks (weeks 17 to
20) of the feeding period. The body weight of rats wasof this progressive renal disorder. Using the kidneys of
rats with GeO2-induced nephropathy, we therefore ex- monitored at four week intervals throughout the study.
amined the expression of ED1-positive cells (macro-
Kidney preparationphages/monocytes), TGF-b1 mRNA and collagen type IV
mRNA and protein, which are considered to play key Under light ether anesthesia, both kidneys were thor-
oughly perfused with ice-cold phosphate-buffered salineroles in the development of the tubulointerstitial fibrosis
associated with GeO2-induced nephropathy. Concomi- (PBS) through the bifurcation of the aorta [17, 18]. The
kidneys were immediately taken out and decapsulated.tantly, we explored whether l-arginine had an inhibitory
effect on their expression in the kidneys of rats with One kidney was longitudinally sliced at a thickness of
approximately 3 mm. The sliced preparations were thenGeO2-induced nephropathy.
fixed overnight at 48C and 4% paraformaldehyde dis-
solved in PBS in preparation for the subsequent immu-
METHODS
nohistochemical study. The other kidney was dissected
Chemicals and reagents on ice into the cortex and the medulla. The cortex was
used for the extraction of total RNA.l-Arginine was purchased from Life Technologies
(Gibco BRL, Baltimore, MD, USA). Monoclonal mouse
Immunohistochemical studyantibody (Ab) recognizing the cytoplasmic antigen ED1
of macrophages/monocytes (monoclonal Ab ED1) was The immunohistochemical analysis was performed as
reported previously [17, 18]. To remove paraffin, kidneysupplied by BMA Biomedicals Ltd. (Augst, Switzerland).
Polyclonal rabbit Ab against TGF-b1 was purchased from sections (4 mm) were incubated serially in xylene (33),
99.5% ethanol (32) and 70% ethanol (31). H&E stain-Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
Polyclonal rabbit Ab against collagen type IV was ob- ing was then carried out on the sections from each group
of rats. For the immunohistochemical study, the sectionstained from LSL C. Ltd. (Tokyo, Japan). Immunohisto-
chemical staining kits were supplied by Dako Corp. (San were treated with 0.125% tripsin diluted with a TBS
buffer solution (50 mmol/L Tris-HCl, pH 7.8, 0.05%Diego, CA, USA). Block Ace, a blocking reagent was
purchased from Dainippon Pharmaceutical Corp., Ltd. Tween 20, 0.3 mol/L NaCl and 0.02% NaN3). The endog-
enous peroxidase activity of the sections was inactivated(Osaka, Japan).
using a 0.3% hydrogen peroxide treatment. The sections
Experimental protocol were then blocked in a blocking solution (20% Block
Ace), and incubated for two hours with either mono-Germanium dioxide treatment was performed ac-
cording to the protocol reported by Sanai et al [10] with clonal Ab ED1 (1:50 dilution) or antiserum against colla-
gen type IV (1:100 dilution) in a TBS buffer solutionslight modification. Female Wistar rats (approximately
175 g, Japan Biochemical Supplement Center, Tokyo, containing 0.1% bovine serum albumin (BSA). Each
dilution of preimmune serum was used as a negativeJapan) were pair-fed either a diet not containing GeO2
(standard diet; N 5 15) or a diet containing 0.15% GeO2 control. The sections were further incubated with a bio-
tin-conjugated second Ab and horseradish peroxidase-(GeO2 diet; N 5 24) for 20 weeks. The basic compositions
of both diets such as protein, carbohydrates, fat, minerals labeled streptavidin, and stained with diaminobenzidine.
Nucleus staining was carried out with hematoxylin. Inand vitamin mixtures were identical except for the addi-
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addition, double immunostaining for ED1-positive cells Extraction of RNA
and TGF-b1 was done using monoclonal Ab ED1 and The total RNA was extracted from the renal cortex
antiserum against TGF-b1 (1:200 dilution) according to using the guanidinium thiocyanate method [17, 18]. Briefly,
the protocol described above. These antibodies had alka- the renal cortex was homogenized in ice-cold ISOGEN
line phosphatase and horseradish peroxidase, respec- (Nippon Gene, Toyama, Japan) and the total RNA was
tively, through the binding of biotin and streptavidin. precipitated using isopropanol. The RNA pellets were
Color development was performed with fast red/naphtol then washed in 75% ethanol, dried and dissolved in RNase-
and diaminobenzidine, respectively. Monoclonal Ab ED1 free, distilled water. The quantitative analysis of the total
was specific for the cytoplasmic antigen ED1 of macro- RNA was carried out at 260 nm and 280 nm using a
phages/monocytes [18, 19]. The antiserum against colla- Beckman UV 640 spectrophotometer. The OD260 /OD280
gen type IV or TGF-b1 showed no cross reactivity with ratio of all RNA samples used was over 1.9.
laminin, fibronectin and collagen types I, II, III, V and
VI, or with TGF-b2 and TGF-b3 when examined by West- cDNA synthesis and amplification
ern blot analysis. The polymerase chain reaction (PCR) coupled with
the reverse transcription (RT) of RNA was performedDetermination of the ED1-positive cell number
for collagen type IV and TGF-b1 mRNA expression us-The ED1-positive cell number was determined by ing an RNA PCR kit (Takara Biochemicals, Shiga, Ja-
counting the number of cells within the renal cortex that pan) [17, 18]. Total RNA from the renal cortex was
reacted with monoclonal Ab ED1 [16]. Ten randomly reverse transcribed to first-stand cDNA in an RT buffer
chosen fields from the same kidney section were photo- solution consisting of 10 mmol/L Tris-HCl, 50 mmol/L
graphed under 2003 magnification. The ED1-positive KCl, 5 mmol/L MgCl2, 1 mmol/L deoxynucleotide tri-cells were then counted and averaged (cells/2003 field). phosphate (dNTP) mixture, 1 U/ml RNase inhibitor, 0.25
The average number of ED1-positive cells in each group U/ml avian myeloblastosis virus (AMV) reverse tran-
was determined by examining five rats.
scriptase, and 2.5 mmol/L random primers. The incuba-
tion conditions were 308C for 10 minutes and 428C forSemiquantitative analysis of collagen type IV
30 minutes. Following the incubation period, the reactionTo evaluate the severity of GeO2-induced tubulointer- mixture was heated at 998C for five minutes and immedi-stitial fibrosis, the deposition score of collagen type IV
ately chilled to 48C.was determined in the cortical tubulointerstitium of kid-
Polymerase chain reaction amplification was carried outney sections that were immunostained with antiserum
for collagen type IV, TGF-b1, and glyceraldehyde-3-phos-against collagen type IV as reported previously [20]. Fifty
phate dehydrogenase (GAPDH) cDNA obtained fromnonoverlapping fields from the same kidney section were
the renal cortex. In brief, collagen type IV cDNA (363 bp)assigned a score of 0 to 3 under a microscopic examina-
was amplified with 37 cycles in the reaction mixture con-tion (magnification 3200). A score of 0 was assigned when
sisting of the PCR amplification buffer (1 mmol/L Tris-the immunohistochemical appearance was equivalent to
HCl, 50 mmol/L KCl, 4 mmol/L MgCl2, 200 mmol/L dNTPthat of the control kidney. An increasing score of 1 to 3
mixture, and 0.025 U/ml Takara Tag DNA polymerase), 1was assigned depending on the intensity and distribution
mmol/L of collagen type IV cDNA amplification primersof collagen type IV accumulation in the tubulointersti-
(sense: 59-GTGCGGTTTGTGAAGCACCG-39 and anti-tum (1 5 mild deposition; 2 5 moderate deposition; and
sense: 59-GTTCTTCTCATGCACACTT-39 [20]) and re-3 5 severe deposition). The rate of the fields assigned
verse transcribed cDNA obtained from 1 mg of total RNAeach score (X) was calculated as follows.
under the following conditions: denaturation at 948C for
one minute, annealing at 608C for one minute and exten-
sion at 728C for two minutes. Similarly, TGF-b1 cDNAX(%) 5
the number of the
fields assigned each score
50 fields
3 100
(498 bp) and the housekeeping gene, GAPDH cDNA
(515 bp), were amplified with 37 cycles under the sameAlso, the average score exhibiting the severity of tubulo-
amplification protocol in the reaction mixture composedinterstitial fibrosis (Y) was determined as follows.
of the PCR amplification buffer, 1 mmol/L of primers for
each cDNA amplification (TGF-b1, sense, 59-AATACGTY 5
Z0 1 Z1 1 Z2 1 Z3
50 fields CAGACATTCGGGAAGCA-39, and antisense, 59-GTC
AATGTACAGCTGCCGTACACA-39 [21]; GAPDH,
Zn 5 (N: each score) 3 1the number of fieldsassigned the score 2 sense, 59-AATGCATCCTGCACCACCAA-39, and anti-sense, 59-GTAGCCATATTCATTGTCATA-39 [17, 18,
20, 21]) and reverse transcribed cDNA obtained fromThe mean values of X and Y in each group were obtained
from six rats. 0.5 mg of total RNA. A pair of primers for collagen type
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in body weight for 12 weeks after the start of the diet.
Thereafter, the rats showed no substantial changes in
body weight. Rats fed a GeO2 diet had a sluggish increase
in body weight for the initial eight weeks of the diet and
subsequently exhibited a progressive reduction in body
weight. l-Arginine treatment did not affect the body
weight of rats fed a standard (N 5 6) or a GeO2 diet
(N 5 6; data not shown). The changes in body weight
observed in rats fed a GeO2 diet was probably the result
of GeO2 toxicity rather than calorie restriction, as the
two groups of rats were pair-fed isocaloric diets.
To assess the effect of GeO2 on the induction of tubu-
lointerstitial nephropathy, H&E staining was carried out
on kidney sections from rats at 16 weeks after the start
of a standard diet (N 5 6) or a GeO2 diet (N 5 10).
Figure 2 shows representative photomicrographs of the
renal cortex obtained from rats fed either a standard or
a GeO2 diet for 16 weeks. There were no significant
histopathological findings in rats fed a standard diet for
16 weeks (Fig. 2A). The H&E staining, however, indi-
cated tubulointerstitial nephropathy characterized by
Fig. 1. Changes in rat body weight after administration of a standard
leukocyte infiltration into the enlarged tubulointerstitialdiet (s) or a GeO2 diet (d).
space in rats fed a GeO2 diet (Fig. 2B). There was a loss
of proximal tubules, distal tubules and collecting ducts
in the enlarged tubulointerstitium. This may have been
IV, TGF-b1 or GAPDH cDNA amplification has been the result of tubular epithelial cell injury caused by GeO2
confirmed to specifically amplify the objective cDNA exposure [10]. In addition, some dilated collecting ducts
through sequencing [20, 21]. In addition, there was a were observed. Glomeruli were mostly intact. These ob-
linear increase in each PCR product at least up to 40 servations were noted in all of the rats examined, thus
cycles when examined using total RNA obtained from indicating that with the dietary protocol used in this
control rats and rats with GeO2-induced nephropathy. study, tubulointerstitial nephropathy develops at latest
by 16 weeks after exposure to GeO2.
Semiquantitative analysis of PCR products Table 1 shows data on the number of ED1-positive
Polymerase chain reaction amplification products were cells found in the tubulointerstitium of the renal cortex
separated utilizing 2.0% agarose gel electrophoresis from control rats and rats with GeO2-induced nephropa-
[17, 18]. The gel, containing ethidium bromide (0.5 mg/ml), thy that either did or did not receive l-arginine (N 5 5
in each group). Figure 3 shows representative photomi-was visualized with UV light and photographed with
crographs of the immunohistochemical staining of ED1-Polaroid Type 667 positive film. The intensity of bands
positive cells in the renal cortex from each group of ratswas measured by densitometry for semiquantification.
(N 5 5). Few ED1-positive cells were detected in controlRelative levels of collagen type IV or TGF-b1 mRNA
rats (Fig. 3A). There was a marked increase in ED1-were determined by the ratio of collagen type IV cDNA/
positive cells found in rats with GeO2-induced nephropa-GAPDH cDNA or TGF-b1 cDNA/GAPDH cDNA.
thy (Fig. 3B) compared to those found in control rats.
Statistical analysis Administration of l-arginine did not influence the num-
ber of ED1-positive cells found in control rats (Fig. 3C),All data reported represent means 6 SD. Compari-
but it significantly decreased the number of these cellssons were evaluated using the unpaired Student’s t-test
found in rats with GeO2-induced nephropathy (Fig. 3D).or two-way analysis of variance (ANOVA) with Stu-
However, the number of ED1-positive cells was still sig-dent’s t-test. Differences were considered significant
nificantly greater in rats with GeO2-induced nephropathywhen P , 0.05.
than in control rats. In addition, no significant expression
of ED1-positive cells was observed in glomeruli from
RESULTS each group of rats.
Figure 1 shows the changes in body weight of rats fed Figure 4 shows representative photomicrographs of
a standard (N 5 9) or a GeO2 (N 5 18) diet for 20 weeks. the double immunostaining for ED1-positive cells (pink)
and TGF-b1 (brown) in the renal cortex of control ratsRats fed a standard diet showed a progressive increase
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Table 1. The number of ED1-positive cells found in the renal gen type IV deposition was the greatest at score 3 in rats
cortices of control rats and rats with GeO2-induced nephropathy with GeO2-induced nephropathy. l-arginine treatmentthat did or did not receive l-arginine
decreased the greatest distribution of collagen type IV
Tap Water l-Arginine deposition to score 1. Consequently, l-arginine treatment
Control GeO2 Control GeO2 significantly reduced the average score of the severity of
0.960.4 55.2619.0a 0.760.4 11.863.8a,b tubulointerstitial fibrosis from 2.28 6 0.19 to 1.26 6 0.15.
Data reported are mean 6 SD of values obtained from five rats. The number However, the average score was still higher in rats with
of ED1-positive cells was determined as described in the Methods section. Com- GeO2-induced nephropathy than in control rats.parisons were based on two-way ANOVA using Student’s t-test.
aP , 0.005 compared to each control value Table 3 shows the relative levels of TGF-b1 and colla-
bP , 0.005 compared to each tap water treatment value gen type IV mRNA (Fig. 6) found in the renal cortex
of control rats and rats with GeO2-induced nephropathy
that either did or did not receive l-arginine (N 5 6 in
each group). TGF-b1 and collagen type IV mRNA wereand rats with GeO2-induced nephropathy (N 5 5 in each
clearly detected in control rats. Both renal tubules andgroup). Nucleus staining was not performed to make the
glomeruli may be the major contributors of TGF-b1contrast of double staining for ED1-positive cells and
mRNA in control rats [11]. Similarly, collagen type IVTGF-b1 clear. There was no significant expression of
mRNA may be derived from renal tubules and peritubu-ED1-positive cells and TGF-b1 in control rats (Fig. 4A).
lar capillaries [20]. Relative to that found in control rats,However, the expression of ED1-positive cells and TGF-b1 the expression of TGF-b1 and collagen type IV mRNAwas markedly increased in GeO2-induced nephropathy was significantly augmented in rats with GeO2-induced(Fig. 4B). The major cells responsible for the expression
nephropathy. l-Arginine treatment had no effect on theof TGF-b1 were ED1-positive cells (Fig. 4C, D). How- expression of TGF-b1 and collagen type IV mRNA inever, there were a small number of TGF-b1 expressing control rats. In contrast, l-arginine treatment substan-tubulointerstitial cells that did not react with monoclonal
tially decreased the expression of TGF-b1 and collagenAb ED1.
type IV mRNA in rats with GeO2-induced nephropathy,Figure 5 shows representative photomicrographs of
although the expression of these substances was still sig-
the immunohistochemical staining of collagen type IV
nificantly increased in rats with GeO2-induced nephropa-in the renal cortex of control rats and rats with GeO2- thy relative to that observed in control rats. The expres-
induced nephropathy that either did or did not receive sion of TGF-b1 and collagen type IV mRNA paralleledl-arginine (N 5 6 in each group). In control rats, slight the number of ED1-positive cells (Table 1) found in both
expression of collagen type IV was detected in the tubu- control rats and rats with GeO2-induced nephropathylar basement membrane and the peritubular capillary that either did or did not receive l-arginine. In addition,
(Fig. 5A). This observation was similar to that reported there was a parallel relationship between the expression
previously [20]. However, the expression of collagen type of mRNA and protein in TGF-b1 and collagen type IV.IV was substantially potentiated in the tubulointerstium
of rats with GeO2-induced nephropathy (Fig. 5B). In
DISCUSSIONparticular, increased deposition of collagen type IV was
observed in the peritubular capillary and the enlarged Long-term oral ingestion of GeO2 or germanium lac-
tubulointerstitial space. l-Arginine treatment did not af- tate citrate, but probably not of carboxyethyl-germanium
fect the expression of collagen type IV in control rats sesquioxide (Ge-132), leads to chronic tubulointerstitial
(Fig. 5C). However, l-arginine treatment markedly re- nephropathy through its cytotoxic effect in humans and
duced the expression of collagen type IV in the tubulo- animals [4, 7, 8, 10]. There is a marked accumulation of
interstium of rats with GeO2-induced nephropathy (Fig. Ge in the renal tissue (particularly in the tubular epithe-
5D). In addition, no significant deposition of collagen lial cells) of GeO2-induced nephropathy [10]. The strik-
type IV was seen in glomeruli from each group of rats. ing feature of this nephropathy is the progressive and
Table 2 shows the deposition score of collagen type IV long-lasting renal damage that is not ameliorated by ces-
in the renal cortex of rats with GeO2-induced nephropa- sation of germanium administration, although urinalysis
thy that either did or did not receive l-arginine (N 5 6 is almost normal [7, 8, 10]. In the present study, we
in each group). A score of 0 to 3 was determined on the showed that long-term administration of GeO2 causes
basis of the representative photomicrographs presented tubulointerstitial nephropathy characterized by leuko-
in Figure 4 (0 5 no deposition or faint deposition as cyte infiltration into the enlarged tubulointerstitium as
shown in Fig. 4A or 4C; 1 5 mild deposition as shown a consequence of tubular epithelial cell injury in rats.
in Fig. 4D; 2 5 moderate deposition showing the inter- The tubular damage occurred in the proximal tubules,
mediate staining of Fig. 4B and 4D; and 3 5 severe distal tubules and collecting ducts. However, Sanai et al
reported previously that GeO2 was primarily cytotoxicdeposition as shown in Fig. 4B). The distribution of colla-
Yanagisawa et al: GeO2-induced nephropathy2280
Fig. 2. Photomicrographs of the kidney sections stained with hematoxylin and eosin. (A) Renal cortex from rats fed a standard diet for 16 weeks.
(B) Renal cortex from rats fed a GeO2 diet for 16 weeks. Invading leukocytes are observed in the enlarged tubulointerstitial space of the renal
cortex from rats fed a GeO2 diet for 16 weeks. Original magnification, 3100.
Fig. 3. Photomicrographs of the immunohistochemical study of ED1-positive cells. (A) Renal cortex from control rats. (B) Renal cortex from
rats with GeO2-induced nephropathy. (C) Renal cortex from control rats treated with l-arginine for 3 weeks. (D) Renal cortex from rats with
GeO2-induced nephropathy treated with l-arginine for 3 weeks. Details of the protocol are described in the Methods section. ED1-positive cell
infiltration was increased in the renal cortex of rats with GeO2-induced nephropathy. l-Arginine treatment, however, reduced ED1-positive cell
infiltration in the renal cortex of these rats. Original magnification, 3200.
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Fig. 4. Photomicrographs of the double immunostaining of ED1-positive cells and transforming growth factor (TGF)-b1. (A) Renal cortex from
control rats (original magnification, 3 200). (B) Renal cortex from GeO2-induced nephropathy (original magnification, 3200). (C and D) Renal
cortex from GeO2-induced nephropathy (original magnification, 3400). Arrows (C and D) show ED1-positive cells (pink) expressing TGF-b1
(brown). Details of the protocol are described in the Methods section. Nucleus staining was not carried out to make the contrast of double staining
clear. Most of the cells responsible for TGF-b1 expression were ED1-positive cells.
in the distal tubules and the collecting ducts [10]. This monoclonal Ab ED1. In general, macrophages, TGF-b1
and collagens, particularly early infiltrating macrophages,result is somewhat different from ours, and suggests that
our study presents a more progressive model of GeO2- play a key role in the pathophysiology of tubulointersti-
tial nephropathy. After the onset of tubulointerstitialinduced nephropathy.
The immunohistochemical/RT-PCR analysis revealed nephropathy, macrophages infiltrate the tubulointersti-
tial lesion and act as chemoattractants, thereby stimulat-a marked increase in the expression of ED1-positive
cells, TGF-b1 mRNA and protein, and collagen type IV ing the proliferation of migrated fibroblasts [22]. Macro-
phages [23], fibroblasts [14, 24] and myofibroblasts [24, 25]mRNA and protein in the renal cortex of rats with GeO2-
induced nephropathy relative to that observed in control are the major TGF-b1 producing cells in fibrosis. TGF-b1
produced the differentiation of fibroblasts into myofi-rats. l-Arginine treatment, although exhibiting no influ-
ence in control rats, significantly reduced the expression broblasts [26] and the transdifferentiation of renal tubule
epithelial cells into myofibroblasts [27]. The resultantof these substances in rats with GeO2-induced nephropa-
thy. There was a parallel relationship between the ex- increase in the profibrotic factor TGF-b1 increases the
synthesis of collagen mRNA and protein in fibroblastspression of ED1-positive cells, TGF-b1 mRNA and pro-
tein, and collagen type IV mRNA and protein in control [11], myofibroblasts [28] and renal tubule epithelial cells
[29]. Thus, the present study indicates that the synthesisrats and rats with GeO2-induced nephropathy that either
did or did not receive l-arginine. However, double im- of collagen type IV may be driven by TGF-b1 that is
derived from invading macrophages and, to a lesser ex-munostaining exhibited a small number of TGF-b1 ex-
pressing tubulointerstitial cells that did not react with tent, derived from tubulointerstitial cells, presumably
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Fig. 5. Photomicrographs of the immunohistochemical study of collagen type IV. (A) Renal cortex from control rats. (B) Renal cortex from rats
with GeO2-induced nephropathy. (C) Renal cortex from control rats treated with l-arginine for 3 weeks. (D) Renal cortex from rats and GeO2-
induced nephropathy treated with l-arginine for 3 weeks. Arrows (A and C) show collagen type IV expression in the tubular basement membrane
and the peritubular capillary. Details of the protocol are described in the Methods section. The expression of collagen type IV was increased in
the renal cortex of rats with GeO2-induced nephropathy. l-Arginine treatment, however, reduced the expression of collagen type IV in the renal
cortex of these rats. Original magnification, 3200.
Table 2. Collagen type IV deposition score in the renal cortices of rats with GeO2-induced nephropathy that did or did not receive l-arginine
Deposition score %
Average
0 1 2 3 score
Tap water 10.063.8 9.363.9 23.769.4 57.0612.9 2.2860.19
l-Arginine 13.364.3 54.067.0a 25.767.3 7.063.9a 1.2660.15a
Data reported are means 6 SD of values obtained from six rats. Criteria for the deposition score of collagen type IV and the average score of collagen type IV
deposition were determined as described in the Methods section. The deposition score of collagen type IV was zero in the renal cortices of control rats (not shown).
Comparisons were based on unpaired Student’s t-test.
aP , 0.005 compared to each tap water treatment value
fibroblasts and/or myofibroblasts in GeO2-induced ne- involvement, and collagen type IV mRNA and protein
expression that are up-regulated in some renal diseasesphropathy. Subsequently, collagen type IV deposition
may contribute to the remodeling of the enlarged tubulo- such as obstructive nephropathy and puromycin-induced
nephrosis [15, 16]. This effect of l-arginine may be re-interstitium that is seen as a consequence of this ne-
phropathy. lated to increased synthesis of nitric oxide (NO) by the
endothelial NO synthase [16, 30]. Similarly, the adminis-It has been recently reported that l-arginine treatment
reduces the ED1-positive cell infiltration and the resul- tration of NO-generating compounds decreases the ex-
pression of ED1-positive cells, TGF-b1 mRNA, and col-tant a-smooth muscle actin (a marker of myofibroblasts)
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Table 3. Relative levels of transforming growth factor-b1 and collagen type IV mRNA found in the renal cortices of control rats and rats
with GeO2-induced nephropathy that did or did not receive l-arginine
Tap water L-arginine
Control GeO2 Control GeO2
Transforming growth factor-b1 0.5760.11 1.6660.15a 0.4960.13 0.9460.26b,d
Collagen type IV 0.5360.06 1.8360.31a 0.6060.16 1.0560.25c,d
Data reported are means (arbitrary units) 6 SD of values obtained from six rats. Relative levels of transforming growth factor-b1 and collagen type IV and mRNA
were determined as described in the Methods section. Comparisons were based on two-way ANOVA using Student’s t-test.
aP , 0.005, bP , 0.01 and cP , 0.025 compared to each control value
dP , 0.005 compared to each tap water treatment value
to preventing the progression of GeO2-induced nephrop-
athy by ameliorating hypertension if GeO2-induced ne-
phropathy develops hypertension.
Nitric oxide also directly inhibits the synthesis of ma-
trix proteins such as collagens [33]. However, there was
a parallel reduction in ED1-positive cell invasion, TGF-b1
mRNA expression, and collagen type IV mRNA and pro-
tein expression in rats with GeO2-induced nephropathy
when the animals were treated with l-arginine. These
results suggest that l-arginine treatment causes a decrease
in collagen type IV accumulation by inhibiting TGF-b1
mRNA expression through the blocking of macrophage
infiltration rather than by directly suppressing collagen
type IV synthesis.
Fig. 6. Photographs of transforming growth factor (TGF)-b1, collagen Of greater interest in the present study is the fact thattype IV (COL IV) and glyceraldehyde-3-phosphate dehydrogenase
l-arginine treatment was still effective in suppressing the(GAPDH) mRNA expression in the renal cortex of control rats (C)
and rats with GeO2-induced nephropathy (Ge). Each mRNA expression fibrotic formation associated with GeO2-induced ne-was determined using the method of reverse transcription-polymerase
phropathy, even when the administration of l-argininechain reaction (see Methods section).
was initiated after the onset of the nephropathy. This
implies a therapeutic effect of l-arginine. As noted pre-
viously, GeO2-induced nephropathy is characterized by
lagen type IV mRNA and protein that is enhanced in progressive renal injury that is not alleviated by cessation
obstructive nephropathy [20], and suppresses TGF-b1 of GeO2 ingestion. Thus, l-arginine treatment appears
mRNA expression and collagen synthesis in cultured to be useful for preventing tubulointerstitial fibrosis asso-
vascular smooth muscle cells and mesangial cells [31, 32]. ciated with this type of renal disorder. Accordingly, it
These observations suggest that the inhibitory effect of may be worth examining whether l-arginine is also bene-
l-arginine treatment on the fibrotic events associated ficial in blocking the fibrotic information following renal
with some renal diseases results from the suppression of damage caused by heavy metal compounds other than
the macrophage/TGF-b1/collagen pathway linked to the GeO2.
fibrotic formation by NO produced through this treat- In summary, the present study demonstrates that long-
ment. Indeed, we have shown in the present study that term administration of GeO2 leads to chronic tubuloin-
l-arginine treatment prevents collagen type IV mRNA terstitial nephropathy. This nephropathy is accompanied
and protein synthesis, as well as suppresses macrophage by macrophage infiltration, a rise in TGF-b1 mRNA and
infiltration and TGF-b1 mRNA expression in the renal protein expression, and an increase in collagen type IV
cortex of rats with GeO2-induced nephropathy. mRNA and protein expression. The increased expression
It is known that l-arginine supplementation amelio- of collagen type IV may play a central role in the forma-
rates systemic and glomerular hypertension [12]. Hyper- tion of tubulointerstitial fibrosis associated with GeO2-
tension usually plays a role in the progression of a variety induced nephropathy. l-Arginine treatment produces an
of renal disorders. Again, hypertension appears with the inhibitory effect on collagen type IV mRNA and protein
development of renal injury in many renal disorders. To synthesis, possibly through suppression of macrophage
the best of our knowledge, it is not apparent that GeO2- infiltration and the resultant TGF-b1 mRNA expression
induced nephropathy leads to hypertension. It is sug- in GeO2-induced nephropathy. Thus, l-arginine treat-
ment may be a means of preventing the tubulointerstitialgested that l-arginine treatment also contributes in part
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